This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Trellis Bioscience, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Milton J Friedman: Innovator in Vaccine Development
Introduction
Milton J Friedman is a prominent inventor based in Alameda, CA (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines against respiratory syncytial virus (RSV). His innovative work has the potential to improve public health outcomes through enhanced vaccine efficacy.
Latest Patents
Milton J Friedman holds a patent for an immunogen that provides an extended protective lifetime against respiratory syncytial virus (RSV). This patent includes improvements to vaccines against RSV, such as G protein CCD portions complexed with monoclonal antibodies (mAb) that block interaction with CX3C-R. Additionally, it features modified forms of mAb to prolong serum half-life, as well as the development of inhalable vaccines.
Career Highlights
Friedman is currently associated with Trellis Bioscience, Inc., where he continues to advance his research in vaccine technology. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges.
Collaborations
One of his notable collaborators is Lawrence M Kauvar, with whom he has worked on various projects aimed at enhancing vaccine development.
Conclusion
Milton J Friedman is a key figure in the field of vaccine innovation, with a focus on improving the effectiveness of immunizations against RSV. His contributions are paving the way for advancements in public health and disease prevention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile